全文获取类型
收费全文 | 2267篇 |
免费 | 58篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 62篇 |
妇产科学 | 76篇 |
基础医学 | 149篇 |
口腔科学 | 76篇 |
临床医学 | 388篇 |
内科学 | 543篇 |
皮肤病学 | 127篇 |
神经病学 | 52篇 |
特种医学 | 8篇 |
外科学 | 238篇 |
综合类 | 43篇 |
一般理论 | 21篇 |
预防医学 | 166篇 |
眼科学 | 20篇 |
药学 | 311篇 |
肿瘤学 | 36篇 |
出版年
2016年 | 20篇 |
2015年 | 16篇 |
2014年 | 24篇 |
2013年 | 43篇 |
2010年 | 44篇 |
2009年 | 45篇 |
2001年 | 21篇 |
1999年 | 39篇 |
1998年 | 66篇 |
1997年 | 92篇 |
1996年 | 108篇 |
1995年 | 83篇 |
1994年 | 76篇 |
1993年 | 67篇 |
1992年 | 75篇 |
1991年 | 76篇 |
1990年 | 75篇 |
1989年 | 64篇 |
1988年 | 62篇 |
1987年 | 49篇 |
1986年 | 61篇 |
1985年 | 45篇 |
1984年 | 53篇 |
1983年 | 44篇 |
1982年 | 42篇 |
1981年 | 39篇 |
1980年 | 41篇 |
1979年 | 38篇 |
1978年 | 43篇 |
1977年 | 36篇 |
1976年 | 24篇 |
1975年 | 21篇 |
1972年 | 21篇 |
1971年 | 21篇 |
1969年 | 17篇 |
1968年 | 24篇 |
1967年 | 17篇 |
1966年 | 15篇 |
1965年 | 15篇 |
1964年 | 16篇 |
1963年 | 19篇 |
1962年 | 17篇 |
1961年 | 19篇 |
1959年 | 33篇 |
1958年 | 57篇 |
1957年 | 52篇 |
1956年 | 39篇 |
1955年 | 47篇 |
1954年 | 40篇 |
1948年 | 24篇 |
排序方式: 共有2330条查询结果,搜索用时 15 毫秒
1.
MATTHEW B. COLLIER C. ANDERSON ENGH JR. JAMES P. MCAULEY STUART D. GINN GERARD A. ENGH 蔡迅梓 《骨科动态》2006,2(2):93-99
背景:从关节和胫骨假体聚乙烯衬垫后表面转移磨损碎屑,是全膝关节置换术后假体周围骨溶解的主要原因。全膝人工关节假体设计随时问而发生变化,例如对胫骨盘近端表面的粗糙度和聚乙烯衬垫的灭菌方法。我们假设胫骨盘表面抛光和采用空气中γ射线照射之外的其他方法对衬垫灭菌,可降低骨溶解的发生率。方法:从1987年至1998年,我们采用后十字韧带保留型的解剖型组配式全膝人工关节假体系列。对300名患者施行365例全膝关节置换术。术后5至10年,对这些患者的膝关节摄正、侧位X线片。由两位关节置换专家对X线片上的骨溶解状况进行单独评定(骨溶解的界定标准为假体周围存在边缘清晰的非线性松质骨丢失区)。结果:在粗糙表面的胫骨盘的242例膝关节中,使用空气中γ射线照射灭菌的衬垫固定,有34%(82例)骨溶解阳性。用惰性气体中γ射线照射或没有照射的衬垫与抛光表面连接的98例膝关节中,有9%(9例)骨溶解阳性。骨溶解与六项因素相关,这些因素为:一项与患者(男性)相关、一项与胫骨盘(近端表面抛光)相关、三项与聚乙烯衬垫(加工的原材料、灭菌方法及存放时间)相关及一项与手术技术(股骨假体与胫骨假体间的过伸)相关。结论:在这类假体设计中,胫骨盘近端表面采用抛光及衬垫采用更为先进的灭菌方法(不用空气中γ射线照射灭菌)能显著减少骨溶解的发生率,但不能避免骨溶解。 相似文献
2.
STEPHEN K. DORDUNOO JAMES L. FORD MICHAEL H. RUBINSTEIN 《The Journal of pharmacy and pharmacology》1997,49(4):390-396
The effect of storage on the physical stability of solid dispersions of triamterene or temazepam in polyethylene glycols was studied using differential scanning calorimetry (DSC), particle-size analysis and dissolution methods. The enthalpies of fusion of the carriers, without included drug and previously fused and crystallized, increased on storage. Analysis of similarly treated solid dispersions, containing either 10% temazepam or 10% triamterene, showed that each drug influenced the morphology of the polyethylene glycol (PEG). The enthalpies and melting points of the solidus components of the dispersions' carriers were initially reduced after preparation, but on storage these increased. The particle sizes of the drugs dispersed in the PEGs increased on storage. The changes in dissolution after storage of triamterene or temazepam dispersions were smaller for dispersions in PEG 1500 than for dispersions in PEGs of higher molecular weight (PEG 2000, PEG 4000 or PEG 6000) in which the reduction in dissolution was particularly marked during the first month of storage. The rank order of changes in dissolution were PEG 1500 ? PEG 2000 < PEG 4000 ~ PEG 6000. 相似文献
3.
4.
Choline deficiency in the baby pig 总被引:1,自引:0,他引:1
5.
6.
7.
HELEN J. GILL JAMES L. MAGGS STEPHEN MADDEN MUNIR PIRMOHAMED & B. KEVIN PARK 《British journal of clinical pharmacology》1996,42(3):347-353
1 Cytochrome P450-mediated bioactivation of sulphamethoxazole to a hydroxylamine has been implicated in the hypersensitivity reactions associated with co-trimoxazole administration. Inhibiting the formation of the hydroxylamine may be one method of preventing the high frequency of toxicity which is observed in HIV-infected patients. Therefore, in this study, we have investigated the ability of fluconazole and ketoconazole, known cytochrome P450 inhibitors, to inhibit the formation of sulphamethoxazole hydroxylamine.
2 Ten healthy male volunteers were given co-trimoxazole (800 mg sulphamethoxazole and 160 mg trimethoprim) alone or 1 h after either fluconazole (150 mg) or ketoconazole (200 mg) in a randomized fashion with a washout period of at least 1 week between each phase. Urine was collected for 24 h, and sulphamethoxazole and its metabolites were quantified by electrospray LC-MS.
3 Ketoconazole had no effect on the urinary recovery of sulphamethoxazole or any of its metabolites. In contrast, fluconazole significantly ( P <0.001) inhibited the formation of sulphamethoxazole hydroxylamine by 50.0±15.1%. Fluconazole also inhibited the oxidation of sulphamethoxazole to the 5-methylhydroxy and 5-methylhydroxy acetate metabolites by 69.9±15.8% and 64.0±12.0%, respectively, but had no effect on the amount of sulphamethoxazole, N4 -acetyl sulphamethoxazole, or sulphamethoxazole N1 -glucuronide excreted in urine.
4 The potential clinical benefit of using fluconazole to prevent hypersensitivity to co-trimoxazole in patients with AIDS needs to be assessed in a prospective study using both metabolite formation and the clinical occurrence of adverse reactions as end-points. 相似文献
2 Ten healthy male volunteers were given co-trimoxazole (800 mg sulphamethoxazole and 160 mg trimethoprim) alone or 1 h after either fluconazole (150 mg) or ketoconazole (200 mg) in a randomized fashion with a washout period of at least 1 week between each phase. Urine was collected for 24 h, and sulphamethoxazole and its metabolites were quantified by electrospray LC-MS.
3 Ketoconazole had no effect on the urinary recovery of sulphamethoxazole or any of its metabolites. In contrast, fluconazole significantly ( P <0.001) inhibited the formation of sulphamethoxazole hydroxylamine by 50.0±15.1%. Fluconazole also inhibited the oxidation of sulphamethoxazole to the 5-methylhydroxy and 5-methylhydroxy acetate metabolites by 69.9±15.8% and 64.0±12.0%, respectively, but had no effect on the amount of sulphamethoxazole, N
4 The potential clinical benefit of using fluconazole to prevent hypersensitivity to co-trimoxazole in patients with AIDS needs to be assessed in a prospective study using both metabolite formation and the clinical occurrence of adverse reactions as end-points. 相似文献
8.
Preservation of All Chordae Tendineae and Papillary Muscle During Mitral Valve Replacement with a Tilting Disc Valve 总被引:1,自引:0,他引:1
HAROLD L. FEIKES M.D. JAMES B. DAUGHARTHY M.D. JESSE E. PERRY M.D. JOHN H. BELL M.D. ROBERT E. HIEB M.D. GILBERT H. JOHNSON P.A.-C. 《Journal of cardiac surgery》1990,5(2):81-85
Mitral valve replacement was performed in 21 patients using a surgical technique that preserves the entire papillary muscle and chordal apparatus. With this technique, the anterior mitral leaflet is split from the center of the free edge toward the annulus. Bilateral incisions are made from the proximal end of this split to the two mitral commissures, detaching the anterior leaflet from the annulus. These two halves of the leaflet, with all chordae intact (corresponding to the anterolateral and posteromedial papillary muscles), are judiciously trimmed to remove areas of leaflet untethered by chordae tendineae and (when necessary) fibrous thickening; then swung posteriorly and sutured to the posterior mitral annulus using mattress sutures with pledgets. This surgical technique is expected to favor the preservation of left ventricular function and avoid occurrence of irreversible left ventricular dilation/dysfunction, and has been used successfully for calcific and degenerative etiologies, using both tilting disc valves and porcine bioprostheses. It is especially useful in the implantation of tilting disc and bileaflet mechanical prostheses because anterior subvalvular chordae tissue may interfere with the disc excursion and relocated to the posterior leaflet annulus. 相似文献
9.
PETER B. AMSTERDAM M.D. JAMES E. TCHENG M.D. 《Journal of interventional cardiology》1997,10(4):249-263
A large body of evidence supports the critical role of thrombus formation in the pathogenesis of acute MI as well as the early ischemic complications after percutaneous coronary interventions. Both platelets and the plasma proteins involved in fibrin formation are intimately involved in the thrombotic process. Recently, pharmacological agents that hinder fibrin formation and platelet activation or aggregation have been developed. These drugs are being tested in patients with acute MI, in conjunction with thrombolytic agents, and in patients undergoing percutaneous coronary interventions. So far, the antiplatelet agents appear very promising in the area of percutaneous coronary intervention. Information on their role in acute myocardial infarction is still too preliminary to draw conclusions. Results with antithrombin agents have been less promising. This article will briefly describe the mechanisms of thrombus formation, detail the mechanism of action of available antithrombotic pharmacological agents, and review recent clinical trials of these agents. 相似文献
10.